These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 19641142

  • 21. Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.
    Christen U, Kimmel R.
    Front Endocrinol (Lausanne); 2020; 11():591083. PubMed ID: 33193102
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Pro-inflammatory β cell small extracellular vesicles induce β cell failure through activation of the CXCL10/CXCR3 axis in diabetes.
    Javeed N, Her TK, Brown MR, Vanderboom P, Rakshit K, Egan AM, Vella A, Lanza I, Matveyenko AV.
    Cell Rep; 2021 Aug 24; 36(8):109613. PubMed ID: 34433033
    [Abstract] [Full Text] [Related]

  • 26. Fulminant type 1 diabetes--an important subtype in East Asia.
    Imagawa A, Hanafusa T.
    Diabetes Metab Res Rev; 2011 Nov 24; 27(8):959-64. PubMed ID: 22069293
    [Abstract] [Full Text] [Related]

  • 27. Insulitis in human type 1 diabetes.
    Hanafusa T, Imagawa A.
    Ann N Y Acad Sci; 2008 Dec 24; 1150():297-9. PubMed ID: 19120316
    [Abstract] [Full Text] [Related]

  • 28. Acceleration of diabetes development in CXC chemokine receptor 3 (CXCR3)-deficient NOD mice.
    Yamada Y, Okubo Y, Shimada A, Oikawa Y, Yamada S, Narumi S, Matsushima K, Itoh H.
    Diabetologia; 2012 Aug 24; 55(8):2238-45. PubMed ID: 22487925
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Distinct Inflammatory Changes of the Pancreas of Slowly Progressive Insulin-dependent (Type 1) Diabetes.
    Aida K, Fukui T, Jimbo E, Yagihashi S, Shimada A, Oikawa Y, Mori Y, Fujii T, Nishida Y, Koyama R, Kobayashi T.
    Pancreas; 2018 Oct 24; 47(9):1101-1109. PubMed ID: 30192315
    [Abstract] [Full Text] [Related]

  • 31. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
    Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P.
    Autoimmun Rev; 2014 Mar 24; 13(3):272-80. PubMed ID: 24189283
    [Abstract] [Full Text] [Related]

  • 32. Enterovirus infection induces cytokine and chemokine expression in insulin-producing cells.
    Nair S, Leung KC, Rawlinson WD, Naing Z, Craig ME.
    J Med Virol; 2010 Nov 24; 82(11):1950-7. PubMed ID: 20872723
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Mouse pancreatic beta cells express MHC class II and stimulate CD4(+) T cells to proliferate.
    Zhao Y, Scott NA, Quah HS, Krishnamurthy B, Bond F, Loudovaris T, Mannering SI, Kay TW, Thomas HE.
    Eur J Immunol; 2015 Sep 24; 45(9):2494-503. PubMed ID: 25959978
    [Abstract] [Full Text] [Related]

  • 36. Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis.
    Frigerio S, Junt T, Lu B, Gerard C, Zumsteg U, Holländer GA, Piali L.
    Nat Med; 2002 Dec 24; 8(12):1414-20. PubMed ID: 12415259
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas.
    Richardson SJ, Leete P, Dhayal S, Russell MA, Oikarinen M, Laiho JE, Svedin E, Lind K, Rosenling T, Chapman N, Bone AJ, nPOD-V Consortium, Foulis AK, Frisk G, Flodstrom-Tullberg M, Hober D, Hyoty H, Morgan NG.
    Diabetologia; 2014 Feb 24; 57(2):392-401. PubMed ID: 24190581
    [Abstract] [Full Text] [Related]

  • 38. Functional redundancy of CXCR3/CXCL10 signaling in the recruitment of diabetogenic cytotoxic T lymphocytes to pancreatic islets in a virally induced autoimmune diabetes model.
    Coppieters KT, Amirian N, Pagni PP, Baca Jones C, Wiberg A, Lasch S, Hintermann E, Christen U, von Herrath MG.
    Diabetes; 2013 Jul 24; 62(7):2492-9. PubMed ID: 23434930
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The lysine deacetylase inhibitor Givinostat inhibits β-cell IL-1β induced IL-1β transcription and processing.
    Dahllöf MS, Christensen DP, Lundh M, Dinarello CA, Mascagni P, Grunnet LG, Mandrup-Poulsen T.
    Islets; 2012 Jul 24; 4(6):417-22. PubMed ID: 23486342
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.